Skip to main content

Reliq Health Technologies, Inc. Announces First Contract to Deploy its iUGO Home Solution

HAMILTON, Ontario, Jan. 28, 2021 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global telemedicine company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today announced that the Company has signed its first contract to deploy its proprietary iUGO Home solution.
The iUGO Home solution uses a wearable Personal Emergency Response System (PERS) device – a watch or pendant – to connect patients to their care team using two-way communication, sensors and automated alerts. iUGO Home uses the wearable PERS device to provide:Fall detection with automated alerts to the patient’s care teamMedication reminders for the patientTwo-way audio communicationAutomated geofencing-based alerts to the care team or family members if a patient wanders outside a defined areaThe PERS device can connect to the iUGO Cloud via WiFi or cellular, and acts as a hub to wirelessly connect to any Bluetooth-enabled biometric devices the patient is using.“We are very excited to have signed our first contract to deploy our iUGO Home product,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “iUGO Home is a highly scalable solution that was designed to support patients in their own homes or in residential care settings such as long term care, skilled nursing and hospice facilities. Using iUGO Home allows facility staff to receive alerts if a patient falls, is in distress or attempts to leave the facility, and with two way communication staff can speak to patients to instantly triage the patient and provide reassurance. In the home, our solution supports seniors who are aging in place, giving family members and care providers the comfort of knowing that if their loved one or patient wanders or suffers a fall or other medical emergency, they will receive an immediate alert and will have the ability to speak directly to the patient to assess the situation.”The Company has signed a new contract with a long term care facility in North Texas to provide iUGO Home to their patients. The client will go live next month, and the Company expects to add 3,000 iUGO Home patients in North Texas by the end of the year. iUGO Home represents a new revenue stream for the Company, with average revenues per patient of $30 USD/patient/month, Many of these patients will also be using other iUGO Care products including Remote Patient Monitoring, Chronic Care Management, Transitional Care Management and Behavioral Health Integration, with an average additional revenue per patient of $40 USD/patient/month.About Reliq Health
Reliq Health Technologies is a rapidly growing global telemedicine that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTC as RQHTF and on the WKN as A2AJTB.
ON BEHALF OF THE BOARD“Dr. Lisa Crossley”CEO and DirectorFor further information please contact:Company Contact
Investor Relations at ir@reliqhealth.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”.
We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.Reliq Health Technologies Inc. (the “Company“) does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company’s historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.SOURCE: Reliq Health Technologies Inc.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.